Compounds > ozone
Page last updated: 2024-08-22

ozone and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ozone has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study(ies) available for ozone and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Use of ozone-depleting substances; removal of essential use designations; confirmation of effective date. Direct final rule; confirmation of effective date.
    Federal register, 2007, Apr-27, Volume: 72, Issue:81

    Topics: Air Pollutants; Air Pollution; Albuterol; Androstadienes; Anti-Asthmatic Agents; Beclomethasone; Bronchodilator Agents; Dexamethasone; Ergotamine; Ethanolamines; Glucocorticoids; Humans; Ipratropium; Metered Dose Inhalers; Ozone; United States; Vasoconstrictor Agents

2007